The field of cancer research is rapidly evolving, with a growing focus on the intersection of cancer immunology, gene editing, and epigenetics. This ...

In this installment, we delve into one of the most debated scientific advancements of our time: CRISPR gene-editing ...

‘Cutting edge’ is, for once, a truly apt description when it comes to gene editing – both because the field is pushing medicine into areas we might never have dreamed possible, and because ...

MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell ...

The scientific team at the laboratory is headed by a group of women with a track record in genomic science, molecular ...

While some mutations in the BRCA2 gene clearly indicate risks for breast and prostate cancer, thousands of less-common ...

Beam Therapeutics shows promise in gene therapy for sickle cell disease, but it also has high risks and market expectations.

Scientists from a collaboration of Australian research institutions have proposed that editing multiple genetic variants in ...

Yoltech Therapeutics Co. Ltd. has advanced YOLT-204 into the clinic for the treatment of transfusion-dependent β-thalassemia (TDT). If successful, YOLT-204 may provide an off-the-shelf curative ...

If corn was ever jealous of soybean's relationship with nitrogen-fixing bacteria, advancements in gene editing could one day even the playing field. A recent study shows that gene-edited bacteria can ...

A Brandon scientist says the future of agricultural crop research in Canada will be focused on gene editing and trait study, rather than Genetically Modified Organisms (GMOs).